Quarterly report pursuant to Section 13 or 15(d)

Equity (Details) - Schedule of company???s nonvested stock options granted

v3.22.2.2
Equity (Details) - Schedule of company’s nonvested stock options granted
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Number of Options [Member]  
Equity (Details) - Schedule of company’s nonvested stock options granted [Line Items]  
Number of Options, Nonvested at beginning balance | shares 205,834
Number of Options Granted | shares 660,000
Number of Options Vested | shares (645,834)
Number of Options, Nonvested at ending balance | shares 220,000
Weighted Average Exercise Price [Member]  
Equity (Details) - Schedule of company’s nonvested stock options granted [Line Items]  
Weighted Average Exercise Price, Nonvested at beginning balance | $ / shares $ 1.04
Weighted Average Exercise Price Granted | $ / shares 0.73
Weighted Average Exercise Price Vested | $ / shares (0.85)
Weighted Average Exercise Price, Nonvested at ending balance | $ / shares $ 0.68